Stay updated with breaking news from Bertil Stohnes Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Early diagnosis and treatment of Alzheimer’s disease requires reliable and cost-effective screening methods. Researchers at Karolinska Institutet in Sweden have now discovered that a type of sugar molecule in blood is associated with the level of tau, a protein that plays a critical role in the deve
Early diagnosis and treatment of Alzheimer’s disease requires reliable and cost-effective screening methods. Researchers at Karolinska Institutet in Sweden have now discovered that a type of sugar molecule in blood is associated with the level of tau, a protein that plays a critical role in the development of severe dementia. The study, which is published in Alzheimer's & Dementia, can pave the way for a simple screening procedure able to predict onset ten years in advance.
A newly developed blood test can detect brain-derived tau (BD-tau), a biomarker of Alzheimer's disease neurodegeneration.